Hayman Capital develops new Healthcare Investment Strategy: Kill Drug Patents

June 15th, 2015
| More
If you can’t find any good long/short opportunities, you can just create them; which is what hedge fund manager Kyle Bass is doing in the pharmaceutical industry. As reported in the Wall Street Journal, the high profile head of Hayman Capital Management, seeks to create his shorting opportunities by killing vulnerable drug patents of pharmaceutical companies, while opening long positions on rival drug companies that would benefit.

While Hayman Capital is targeting Pharma companies with its new strategy, the firm’s commitment to the sector overall is not enough to position it on The Top Healthcare, Pharma & Biotech Hedge Fund List.

Operating under an organization Kyle Bass created – the Coalition for Affordable Drugs – Kyle Bass identifies and challenges patents he deems to be specious and that are likely candidates to be invalidated by a patent office panel known as Inter Partes Review. Although Kyle Bass insists his strategy has consumer interests at heart (to keep drug prices down), his critics and the CEO’s of targeted companies, such as Jazz Pharmaceuticals and Acorda Therapeutics accuse him of exploiting a highly accessible patent review process simply for profit. Investors can ride along with the strategy for a $1 million investment.
Related Article Tags: Shareholder Activists, Corporate Raiders and Proxy Battles; Hedge Fund Launches and Hedge Fund Closings


More Recent Headlines

Could Surge in Hedge Fund Venture Investments Lead to Next Bubble?

Top Citigroup Executive to join Elliot Management as Chief Operating Officer

Justin Lake leaves JPMorgan to head up a healthcare portfolio at Viking Global Investors

Silicon Valley Firms Won’t Be Calling activist Jesse Cohn’s Bluff Anymore

Healthcare & Biotech Hedge Funds surpass $165 Mark for the first time, as Long/Short Equity Giants bet on Sector

Marc Andreessen Reminds Us Activist Investors Will Always Have Stuff to Do

Activist hedge fund Engaged Capital and Rovi Corp Battle over Board Slates

Top Connecticut Hedge Funds surpass $175 Million Mark; Assets increase 3.2% quarter-over-quarter

California’s Hedge Funds closed out 2014 Strong, Reaching another All-Time High

Tech, Media & Telecom Hedge Funds ride high with 10.3% surge; Lone Pine, Coatue Capital and Tiger Global claim top spots